Citrus Solu-Q

Name: Citrus Solu-Q
Brand: Douglas Laboratories

BrandDouglas Laboratories→Other Combinations Capsule 8 ingredients 1 banned DSLD #30935

Net contents: 30 Caplique(R) Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2014-02-26

2 Ingredients (8)

IngredientGroupSafety

Vitamin EVitamin EConditionally Safe

natural Coenzyme Q10Coenzyme Q-10—

GelatinGelatin—

Medium Chain TriglyceridesMedium chain triglycerides (MCT)—

Polysorbate 80Polysorbate—

Polyglycerol Fatty Acid EstersPolyglycerols—

Citrus Oil extractSweet Orange—

Titanium DioxideTitanium DioxideBanned in ≥1 country

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⛔ Contains an ingredient banned in ≥1 country

Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.

3 Safety cross-reference

Vitamin E — Conditionally Safe

⚠ Increased bleeding risk

⚠ All-cause mortality at >400 IU/day

Coenzyme Q10 — Limited Evidence

⚠ May reduce warfarin efficacy

⚠ Mild GI effects

Titanium Dioxide — Banned in ≥1 country

⚠ EFSA: can no longer be considered safe as food additive (2021)

⚠ Genotoxicity concern (nanoparticles)

4 Label claims

• All Other

5 Data source

DSLD ID30935

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2014-02-26

6 More from Douglas Laboratories

View Douglas Laboratories Safety Scorecard → 788 products

A-Potene 10 A-Potene 25 A-Retic Natural Herbal Formula A-Retic Natural Herbal Formula A.R. Formula A.R.M.D. Eye Support

7 Cite this page

Vancouver

Pkhakadze G. Citrus Solu-Q — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 21]. Available from: https://supplement.ge/products/citrus-solu-q-30935/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG